2. Introduction
ā¢ 6th most common cancer in the world
ā¢ Very poor survival rate
ā¢ Common in China , South Africa & Asian Countries
ā¢ India - Karnataka & Orissa
ā¢ Less common - American and European countries
8. Direct Spread
ā¢ More favorable - Lack of serosal layer
ā¢ Upper third - Spreads to muscular layer
ā¢ Adheres to left main bronchi, trachea , recurrent
laryngeal nerve , aorta
ā¢ May perforate and cause mediastinhtis
ā¢ May adhere to pleura also
9. Lymphatic Spread
ā¢ Spread by lymphatic permeation & lymphatic
embolisation
ā¢ Can cause satellite nodules
ā¢ Neck - Supra clavicular lymph nodes
ā¢ Abdomen - Coeliac Lymph nodes
ā¢ Blood Spread - Liver , Lungs, Brain, Bones
11. ā¢ Recent onset of dysphagia
ā¢ Regurgitation
ā¢ Anorexia, severe loss of weight, cachexia
ā¢ Substernal pain, abdominal pain
ā¢ Liver secondaries ,ascites
ā¢ Bronchopneumonia,melaena
12. ā¢ Features of bronchoesophageal fistula in carcinoma of upper 3rd esophagus
ā¢ Left supra clavicular lymph nodes may be palpable
ā¢ Hoarseness of voice due to involvement of recurrent laryngeal nerve
ā¢ Hiccough due to phrenic nerve involvement
ā¢ backpain
13. TNM staging & histological grading
ā¢ T 0 ā NO primary tumour
ā¢ T 1a -invasion into lamina propria,muscularis mucosa
ā¢ T 1b-submucosa
ā¢ T 2-muscularis propria
ā¢ T 3-paraesophageal tissues(adventitia)
ā¢ T 4a-resectable adjacent structures(pleura,pericardium,diaphragm)
14. ā¢ T4b-unresectable adjacent structures(aorta,vertebral body,trachea)
ā¢ N STATUS-NODES
ā¢ N 0-no regional lymph node metastasis
ā¢ N 1- 1 to 2 positive regional lymph nodes
ā¢ N 2-3 to 6 positive regional lymph nodes
ā¢ N 3-7 or more positive regional lymph nodes
15. M STATUS
ā¢ M O-no distant metastases
ā¢ M I-distant metastases
ā¢ HISTOLOGICAL GRADING
ā¢ G1 āwell differentiated
ā¢ G 2- moderately differentiated
ā¢ G3 āpoorly differentiated
ā¢ G4-undifferentiated
17. INVESTIGATIONS
BARIUM SWALLOW ā Irregular filling defect
- Rat tail lesion on
flouroscopy is typical.
OESOPHAGOSCOPY - To see the lesion, extent
and type
BIOPSY ā For histological type and confirmation
CHEST X-RAY - To look for aspiration pneumonia
18. ā¢ CT ā SCAN - To look for local extension
ā¢ BRONCHOSCOPY - To see invasion in upper 1/3rd carcinoma of oesophagus
ā¢ LARYNGOSCOPY - To identify vocal cord palsy
ā¢ OESOPHAGEAL ENDOSONOGRAPHY - To look for involvement of layers of oesophagus, nodes, cardia
and left lobe of liver
19. ā¢ ULTRASOUND ABDOMEN ā To look for liver and lymph nodes state in abdomen
ā¢ ENDOSCOPIC OESOPHAGEAL STAINING ā WITH LABELLED IODINE
RESULTS : Normal mucosa ā Brown
In carcinoma ā Remains pale
(Mucosa in carcinoma doesnāt take up the iodine)
20. ā¢ BLOOD TESTS - Haematocrit, ESR, LFT
ā¢ LAPROSCOPY - Used to see peritoneal spread
liver and nodal spread
ā¢ VIDEO- ASSISTED THORACOSCOPIC APPROACH ā To stage the carcinoma of oesophagus and to identify
the operability and nodal status
ā¢ ENDOSCOPIC MUCOSAL RESECTION (EMR) ā Itās a diagnostic biopsy tool
21. ā¢ CHROMOENDOSCOPY MAGNIFICATION ENDOSCOPIES ( NEWER METHODS) ā local topical application of
different stains will improve the tumor localisation, features and diagnosis
STAINS USED:-
1) Absorptive ā LUGOLS
METHYLENE BLUE
absorbed by specific cell membrane
22. 2) Contrast ā INDIGOCARMINE - permeate into mucosal crevices showing irregularity
3) Reactive ā CONGO RED
-PHENYL RED
Show color change due to reaction with cell chemicals
ā¢ NEWER MODALITIES OF EVALUATION :
*Flow cytometry
*P53 immunohistochemistry
*Optic coherance tomography
*Spectroscopy
23. TREATMENT
20% Oesophagel cancers are early and
curable
THOSE CONFIRMED:
š”Ŗ With absence of Nodal spread -
RADICAL OESOPHAGECTOMY
*Proximal extent: 10cms above
macroscopic tumor
24. * Distal extent : 5cm from macroscopic
tumor
* Proximal stomach is removed:
especially in the lower 1/3rds of the
tumor
ļæ½If nodes are involved-
MULTIMODAL APPROACH
*Curative resection
* Radiotherapy
* Chemotherapy
25. ļæ½If >5% lymph nodes are involved:-
POOR PROGNOSIS
š”ŖIf 5/<5% lymph nodes are involved:-
CURATIVE RESECTION
āNEO ADJUVANT THERAPY-
Chemotherapy and radiotherapy prior to
surgery may improve the survival
26. āAGGRESSIVE CHEMORADIATION-
Curative therapy
In some patients especially with upper
1/3rd growths and in patients who are
unfit for surgery
In remaining 80% PALLIATION is the main
modality of treatment
27. ā¢ Approaches for different level tumors:
1)POST CRICOID TUMOR
* Treated by radiotherapy- radical
radiotherapy with 5000-6000 rads.
ļæ½Often pharyngectomy is done along
with gastric and colonic transposition.
ļæ½Complications are more in this
procedure.
28. 2) UPPER THIRD GROWTH
Treated by radiotherapy
ļæ½If it is early and operable,
Mc Keown 3 phased oesophagectomy and
anastamosis is done in the neck
*initially laparotomy- to mobilise stomach
* then thoracotomy- to mobilise
oesophagus
* anastamosis between pharynx and
stomach is done in the neck
30. Laparotomy š”Ŗ pyloroplasty š”Ŗ thoracotomy
š”Ŗ growth with tumor is mobilised š”Ŗ
partial oesophagectomy and
oesophagogastric anastamosis in thorax
š”Ŗ Intercostal tube drainage is placed
during closure
ā¢ Right gastroepiploic vessels should be
retained
ā¢ Azygous vein should be ligated securely
ā¢ Mediastinal nodes should be dissected
ā¢ Thoracic duct ligated if needed
31. COMPLICATIONS
Complications in this operation are
Pulmonary-broncho pneumonia
-emphyema
Anastomotic leak
Mediastinitis
Oesophagitis
Sepsis
If growth is inoperable-palliative
radiotherapy
32. 4)LOWER THIRD GROWTH:
ā¢ Partial oesophago gastrectomy is done
with oesophago gastric anastomosis
Approach-left thoraco abdominal
ā¢ Orringer approach:
palliative surgery
i.e,transhiatal blind total oesophagectomy
with anastamosis in the left side of the
neck